Skip to main content
. 2022 Dec 29;15(1):201. doi: 10.3390/cancers15010201
CI confidence interval
CNV copy number variants
CPG cancer-predisposition genes
DDR DNA damage repair
HBV hepatitis B virus
HCC hepatocellular carcinoma
HCV hepatitis C virus
MAF minor allele frequency
MRN MRE11-RAD50-NBN
NASH non-alcoholic steatohepatitis
OR odds ratio
PARPi PARP1 inhibitors
PV pathogenic/likely pathogenic germline variant
PMC population-matched controls